Megan Grossman Co-Chairs Drug & Device Defense Conference in Philadelphia


August 1, 2014

Segal McCambridge is pleased to announce that Megan Grossman, Philadelphia Shareholder, was invited to co-chair HB Litigation Conferences’ Drug & Device Defense Conference at the Hub Cira Center in Philadelphia on October 22, 2014. The conference will focus on emerging litigation and regulatory developments.

Ms. Grossman is co-chairing the event with Dechert LLP Counsel Michelle Hart Yeary. This is HB’s first event focused exclusively on defense drug and device litigation. Topics will include keeping up with the FDA, modern sales and marketing strategies for drugs and medical devices, the top legal issues in the field for 2014, and the relationship between the insurance counsel and the outside counsel.

Having started her career in the biomedical field, Ms. Grossman now focuses her practice on representing various medical device and pharmaceutical companies in products liability matters relating to life sciences and biotechnology. She represents medical device companies in claims arising out of alleged malfunctions of surgical equipment, instruments, and implants; defending pharmaceutical companies in actions arising out of personal injury claims involving prescription medicines or over-the-counter (OTC) drugs; defending companies in relation to claims involving clinical trials; and serving as defense counsel in numerous mass-tort litigation both locally and nationwide.